Anti-ULBP3 抗体 [EPR22321-99] (ab300102)
Key features and details
- Produced recombinantly (animal-free) for high batch-to-batch consistency and long term security of supply
- Rabbit monoclonal [EPR22321-99] to ULBP3
- Suitable for: Dot blot, Flow Cyt, WB, IP
- Reacts with: Human
Related conjugates and formulations
製品の概要
-
製品名
Anti-ULBP3 antibody [EPR22321-99]
ULBP3 一次抗体 製品一覧 -
製品の詳細
Rabbit monoclonal [EPR22321-99] to ULBP3 -
由来種
Rabbit -
アプリケーション
適用あり: Dot blot, Flow Cyt, WB, IPmore details
適用なし: ICC/IF or IHC-P -
種交差性
交差種: Human
非交差種: Mouse, Rat -
免疫原
Recombinant fragment. This information is proprietary to Abcam and/or its suppliers.
-
ポジティブ・コントロール
- WB: Whole cell lysates: SW480 (human colorectal adenocarcinoma epithelial cell), MDA-MB-231 (human breast adenocarcinoma epithelial cell), HeLa, MCF7 (human breast adenocarcinoma epithelial cell), NAMALWA (human burkitt's lymphoma b lymphocyte), Raji (human Burkitt's lymphoma b lymphocyte). Human testis tissue lysate. Flow cyt.: MCF7, Hela, Raji, NAMALWA. IP: MDA-MB-231 (human breast adenocarcinoma epithelial cell) whole cell lysate. DB: Human ULBP3 recombinant protein
-
特記事項
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free production
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
製品の特性
-
製品の状態
Liquid -
保存方法
Shipped at 4°C. Store at +4°C short term (1-2 weeks). Upon delivery aliquot. Store at -20°C long term. Avoid freeze / thaw cycle. -
バッファー
pH: 7.20
Preservative: 0.01% Sodium azide
Constituents: 59% PBS, 40% Glycerol (glycerin, glycerine), 0.05% BSA -
Concentration information loading...
-
精製度
Protein A purified -
ポリ/モノ
モノクローナル -
クローン名
EPR22321-99 -
アイソタイプ
IgG -
研究分野
関連製品
-
Alternative Versions
-
Compatible Secondaries
-
Isotype control
アプリケーション
The Abpromise guarantee
Abpromise保証は、 次のテスト済みアプリケーションにおけるab300102の使用に適用されます
アプリケーションノートには、推奨の開始希釈率がありますが、適切な希釈率につきましてはご検討ください。
アプリケーション | Abreviews | 特記事項 |
---|---|---|
Dot blot |
1/1000.
|
|
Flow Cyt |
1/500.
|
|
WB |
1/1000. Detects a band of approximately 30 kDa (predicted molecular weight: 28 kDa).
|
|
IP |
1/30.
|
特記事項 |
---|
Dot blot
1/1000. |
Flow Cyt
1/500. |
WB
1/1000. Detects a band of approximately 30 kDa (predicted molecular weight: 28 kDa). |
IP
1/30. |
ターゲット情報
-
機能
Ligand for the KLRK1/NKG2D receptor, together with at least ULBP1 and ULBP2. ULBPs activate multiple signaling pathways in primary NK cells, resulting in the production of cytokines and chemokines. Binding of ULBPs ligands to KLRK1/NKG2D induces calcium mobilization and activation of the JAK2, STAT5, ERK and PI3K kinase/Akt signal transduction pathway. Has lower affinity for KLRK1/NKG2D compared to ULBP1 and ULBP2 and induces weaker signaling responses than does ULBP2 or ULBP1. -
配列類似性
Belongs to the MHC class I family. -
細胞内局在
Cell membrane. - Information by UniProt
-
参照データベース
- Entrez Gene: 79465 Human
- Omim: 605699 Human
- SwissProt: Q9BZM4 Human
- Unigene: 15422 Human
- Unigene: 326556 Human
-
別名
- ALCAN- gamma antibody
- ALCAN-gamma antibody
- N2DL-3 antibody
see all
画像
-
All lanes : Anti-ULBP3 antibody [EPR22321-99] (ab300102) at 1/1000 dilution
Lane 1 : SW480 (human colorectal adenocarcinoma epithelial cell) whole cell lysate
Lane 2 : MDA-MB-231 (human breast adenocarcinoma epithelial cell) whole cell lysate
Lane 3 : HeLa (human cervix adenocarcinoma epithelial cell) whole cell lysate
Lane 4 : MCF7 (human breast adenocarcinoma epithelial cell) whole cell lysate
Lysates/proteins at 20 µg per lane.
Secondary
All lanes : Goat Anti-Rabbit IgG H&L (HRP) (ab97051) at 1/50000 dilution
Predicted band size: 28 kDa
Observed band size: 30 kDa why is the actual band size different from the predicted?
Exposure time: 3 minutesBlocking and dilution buffer and concentration: 5% NFDM/TBST.
Exposure time: 3 minutes.
Low expression cell line: MCF7(PMID: 25217158).
-
All lanes : Anti-ULBP3 antibody [EPR22321-99] (ab300102) at 1/1000 dilution
Lane 1 : NAMALWA (human burkitt's lymphoma b lymphocyte) whole cell lysate
Lane 2 : Raji (human burkitt's lymphoma b lymphocyte) whole cell lysate
Lysates/proteins at 20 µg per lane.
Secondary
All lanes : Goat Anti-Rabbit IgG H&L (HRP) (ab97051) at 1/20000 dilution
Predicted band size: 28 kDa
Observed band size: 30 kDa why is the actual band size different from the predicted?
Exposure time: 3 minutesBlocking and dilution buffer and concentration: 5% NFDM/TBST.
Exposure time: 3 minutes.
Low expression: Raji (PMID: 12414645, 11827464).
-
Anti-ULBP3 antibody [EPR22321-99] (ab300102) at 1/1000 dilution + Human testis tissue lysate at 20 µg
Secondary
Goat Anti-Rabbit IgG (HRP) with minimal cross-reactivity with human IgG at 1/2000 dilution
Predicted band size: 28 kDa
Exposure time: 3 minutesBlocking and dilution buffer and concentration: 5% NFDM/TBST.
Exposure time: 3 minutes.
-
Flow cytometric analysis of Raji (human burkitt's lymphoma b lymphocyte, Left) / NAMALWA (human burkitt's lymphoma b lymphocyte, Right) labeling ULBP3 with ab300102 at 1/500 dilution (Red) compared to isotope control Rabbit monoclonal IgG (ab172730) (Black) and an unlabelled control (cells without incubation with primary antibody and secondary antibody) (Blue). Goat anti-Rabbit IgG (Alexa Fluor® 647, ab150083) at 1/2000 dilution was used as secondary antibody.
Gated on viable cells.
Low expression: Raji (PMID: 12414645, 11827464). -
Flow cytometric analysis of MCF7 (human breast adenocarcinoma epithelial cell, Left) / HeLa (human cervix adenocarcinoma epithelial cell, Right) labeling ULBP3 with ab300102 at 1/500 dilution (Red) compared to isotope control Rabbit monoclonal IgG (ab172730) (Black) and an unlabelled control (cells without incubation with primary antibody and secondary antibody) (Blue). Goat anti-Rabbit IgG (Alexa Fluor® 647, ab150083) at 1/2000 dilution was used as secondary antibody.
Gated on viable cells.
Low expression: MCF7 (PMID: 25217158). -
ULBP3 was immunoprecipitated from MDA-MB-231 (human breast adenocarcinoma epithelial cell) whole cell lysate 10 μg with ab300102 at 1/30 dilution (2µg in 0.35 mg lysates). Western blot was performed on the immunoprecipitate using ab300102 at 1/1000 dilution. VeriBlot for IP secondary antibody(HRP)(ab131366) was used at 1/5000 dilution.
Lane 1: MDA-MB-231 (human breast adenocarcinoma epithelial cell) whole cell lysate 10 μg (Inset)
Lane 2: ab300102 IP in MDA-MB-231 (human breast adenocarcinoma epithelial cell) whole cell lysate
Lane 3: Rabbit monoclonal IgG (ab172730) instead of ab300102 in MDA-MB-231 (human breast adenocarcinoma epithelial cell) whole cell lysate
Blocking and dilution buffer and concentration: 5% NFDM/TBST.
Exposure time: 119 seconds.
-
Dot blot analysis of ULBP3 using ab300102 at 1:1000 followed by a Goat Anti-Rabbit IgG, (H+L), Peroxidase conjugated (ab97051) at 1:100,000 dilution.
Lane 1: Human ULBP3 recombinant protein
Lane 2: Human ULBP1 recombinant protein
Lane 3: Human ULBP2 recombinant protein
Lane 4: Human ULBP5 recombinant protein
Lane 5: Human ULBP6 recombinant proteinExposure time: 3 minutes
Blocking and dilution buffer and concentration: 5% NFDM/TBST.
No cross-reactivity with other family members.
プロトコール
To our knowledge, customised protocols are not required for this product. Please try the standard protocols listed below and let us know how you get on.
データシートおよび資料
-
SDS download
-
Datasheet download
Certificate of Compliance
参考文献 (1)
ab300102 は 1 報の論文で使用されています。
- Zhang KJ et al. LncRNA TYMSOS facilitates breast cancer metastasis and immune escape through downregulating ULBP3. iScience 26:107556 (2023). PubMed: 37664624